Novo Nordisk’s Wegovy weight loss drug launches in the Uk

Novo Nordisk’s Wegovy weight loss drug launches in the Uk


Offers of the weight-loss drug Wegovy from the pharmaceutical business Novo Nordisk lie on the income counter in a Danish pharmacy.

Stefan Trumpf | Photo Alliance | Getty Photographs

Novo Nordisk introduced its Wegovy pounds decline injection in the U.K. on Monday, advancing the drug’s rollout in Europe regardless of ongoing source constraints.

The Danish pharmaceutical giant stated that the weekly injection would be available in the beginning “through a controlled and constrained launch,” with only certain patients suitable to acquire the drug on the country’s National Overall health Services.

To qualify for procedure, sufferers ought to be on the NHS’s fat administration company, have at the very least 1 pounds-relevant affliction and have a human body mass index of 35, according to suggestions outlined by the Nationwide Institute for Care and Excellence.

The drug will also be out there privately via a “registered healthcare experienced,” Novo Nordisk stated in a assertion, without introducing even further detail.

The corporation did not react to a CNBC request for comment above the cost of the drug.

In the U.S., Wegovy has a record selling price of $1,350 for a every month dose, whilst in Europe it retails for all around 170 to 300 euros ($190-$330) per month.

British insurance policy business Aviva, which offers private health insurance plan to around 1.1 million Brits, on Monday reported that Wegovy would not be covered under its policy, in accordance to Reuters.

‘Closely monitoring’ provide troubles

Wegovy’s U.K. expansion comes just in excess of a month soon after the drug introduced in Germany — its third European marketplace at the time, soon after Denmark and Norway.

Surging demand for the body weight decline drug, as perfectly as a sequence of clinical research which stage to its broader overall health positive aspects, have shot the firm’s shares to record highs. On Friday, it briefly unseated French luxurious goods behemoth LVMH to develop into Europe’s most precious firm.

'Miracle' drugs could remake the weight loss industry

Supply constraints proceed to weigh large on the drug’s rollout, with CEO Lars Fruergaard Jorgensen telling a Reuters Newsmakers occasion very last thirty day period that it could be “some a long time” ahead of the company can satisfy all shoppers.

In the U.K., Novo Nordisk claimed that “a proportion” of out there offer would be allocated particularly for NHS cure, and that the organization would operate with healthcare skilled to ensure that “clients with the optimum unmet clinical will need” are prioritized.

“We are intently checking Wegovy demand and are operating with regulators and providers to make sure people dwelling with being overweight can have entry to and stay on treatment,” it included.

The organization has also limited provisions in other markets. In Could, it minimize the U.S. supply of starter doses to ensure continuity for current sufferers, though in Germany it advised health professionals to “prescribe responsibly,” limiting prescriptions to clients with medical demands.



Resource

Stock futures slip ahead of the Federal Reserve’s rate decision: Live updates
World

Stock futures slip ahead of the Federal Reserve’s rate decision: Live updates

Traders work at the New York Stock Exchange on June 17, 2025. NYSE U.S. stock futures inched lower on Tuesday night, as traders brace for the Federal Reserve’s rate policy decision due Wednesday afternoon. Futures tied to the Dow Jones Industrial Average slipped 99 points, or 0.2%. S&P 500 futures shed 0.2%, while Nasdaq 100 […]

Read More
India regulator says no ‘major safety concerns’ on Air India’s Boeing 787 fleet
World

India regulator says no ‘major safety concerns’ on Air India’s Boeing 787 fleet

A tail of an Air India Boeing 787 Dreamliner plane that crashed is seen stuck on a building after the incident in Ahmedabad, India, June 12, 2025. Amit Dave | Reuters India’s aviation safety watchdog said on Tuesday surveillance conducted on Air India’s Boeing fleet did not reveal any major safety concerns, days after one of its jets […]

Read More
This AI infrastructure leader is setting up for a move to all-time highs, according to the charts
World

This AI infrastructure leader is setting up for a move to all-time highs, according to the charts

Credo Technology is a relatively new company that came public in 2022 at an approximate $1.5 billion valuation. Amidst the AI boom in the past three years, this company has grown quickly to a $13 billion market cap company. From the looks of things, the stock is going higher. We added the name to our Active […]

Read More